BioXcel Therapeutics, Inc. Operating Lease, Liability, Noncurrent
BioXcel Therapeutics, Inc. (BTAI) had Operating Lease, Liability, Noncurrent of $0 as of 2025-12-31, per its 10-K filed 2026-03-27.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OperatingLeaseLiabilityNoncurrent · last filed 2026-03-27
- 2025-12-31: Operating Lease, Liability, Noncurrent $0.00.
- 2025-09-30: Operating Lease, Liability, Noncurrent $0.00.
- 2024-12-31: Operating Lease, Liability, Noncurrent $65.00K.
- 2024-09-30: Operating Lease, Liability, Noncurrent $161.00K.
| Period end | Operating Lease, Liability, Noncurrent |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-27 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-12 |
| 2024-12-31 | $65.00K 10-K · filed 2026-03-27 |
| 2024-09-30 | $161.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $256.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $350.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $440.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $529.00K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $617.00K 10-Q · filed 2023-08-14 |
| 2023-03-31 | $703.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $786.00K 10-K · filed 2024-03-22 |
| 2022-09-30 | $868.00K 10-Q · filed 2022-11-14 |
| 2022-06-30 | $949.00K 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.03M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $1.10M 10-K · filed 2023-03-16 |
| 2021-09-30 | $1.18M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $1.25M 10-Q · filed 2021-08-10 |
| 2021-03-31 | $1.33M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $1.40M 10-K · filed 2022-03-11 |
| 2020-09-30 | $1.47M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $907.00K 10-Q · filed 2020-08-14 |
| 2020-03-31 | $961.00K 10-Q · filed 2020-05-12 |
| 2019-12-31 | $1.03M 10-K · filed 2021-03-12 |
| 2019-09-30 | $1.07M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $1.11M 10-Q · filed 2019-08-06 |
| 2019-03-31 | $1.15M 10-Q · filed 2019-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |